Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase 1 randomized controlled trial to evaluate the safety and immunogenicity of a HIV monomeric gp120 protein B-cell lineage targeting HIV vaccine in healthy adults.

medRxiv : the preprint server for health sciences·2026
Same author

Menstruation is associated with cyclical granulysin peaks in vaginal secretions despite stable expression by cervicovaginal immune cells.

bioRxiv : the preprint server for biology·2026
Same author

Long-read deep sequencing reveals high rates of multilineage transmission and rapid viral population changes in acute HIV infection.

Nature communications·2026
Same author

Priming of Multiple HIV Neutralizing B Cell Precursors in Humans.

medRxiv : the preprint server for health sciences·2026
Same author

Tenofovir, Interferon Pathways, and Mucosal Immunity: Implications for People Living With HIV.

American journal of reproductive immunology (New York, N.Y. : 1989)·2026
Same author

Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, VRC07-523LS, and PGT121.414.LS infused intravenously or subcutaneously (HVTN 140/HPTN 101 part B): a phase 1, randomised trial.

The lancet. HIV·2026

Related Experiment Video

Updated: Dec 29, 2025

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

9.0K

Setting the stage: host invasion by HIV.

Florian Hladik1, M Juliana McElrath

  • 1Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.

Nature Reviews. Immunology
|May 13, 2008
PubMed
Summary

Recent advances in technology have improved our understanding of how the human immunodeficiency virus (HIV) infects the body through mucosal transmission. Future research will focus on identifying knowledge gaps to develop effective HIV prevention strategies.

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Mucosal transmission of human immunodeficiency virus (HIV) remains a significant global health challenge, infecting millions annually.
  • Understanding the initial molecular and cellular events following viral exposure is crucial for effective prevention.

Purpose of the Study:

  • To review current concepts of immediate events following HIV exposure at genital mucosal sites.
  • To identify knowledge gaps relevant for future HIV prevention strategies.

Main Methods:

  • Utilized new technologies and improved techniques for ex vivo human tissue isolation and in vitro cellular models.
  • Employed more relevant in vivo animal challenge systems for studying HIV transmission.

Main Results:

More Related Videos

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
11:14

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

Published on: October 12, 2018

9.5K
An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
07:39

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells

Published on: August 15, 2012

14.1K

Related Experiment Videos

Last Updated: Dec 29, 2025

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
08:15

Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

Published on: January 31, 2020

9.0K
Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
11:14

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

Published on: October 12, 2018

9.5K
An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
07:39

An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells

Published on: August 15, 2012

14.1K

  • Recent investigations have expanded knowledge of HIV's molecular and cellular foothold acquisition.
  • Current concepts of immediate events post-viral exposure at mucosal sites have been elucidated.

Conclusions:

  • Further research is needed to address knowledge gaps in early HIV mucosal transmission.
  • Identifying these gaps will shape future strategies for effective HIV prevention.